Table 1 Study population characteristics (n = 372).
From: Different histopathologic profiles and outcomes between sun-exposed BCC and non-sun-exposed BCC
Patient with SEBCC | Patient with NSEBCC | p-value | |
|---|---|---|---|
Patient number (%) | 338 (90.9%) | 34 (9.1%) | — |
Men/ Women (n) | 213/125 | 23/11 | p = 0.593 |
Age at onset, mean ± SD (range) | 71.8 ± 13.7 (11-99) | 70.5 ± 12.1 (43-86) | p = 0.576* |
Duration of follow up (year), mean ± SD (range) | 4.51 ± 4.2 (0-26) | 4.94 ± 4.3 (0-19) | p = 0.564* |
Co-morbidities (%) | |||
DM | 89 (26.3) | 7 (20.6) | p = 0.466 |
HT | 156 (46.2) | 17 (50.0) | p = 0.668 |
CKD | 24 (7.1) | 6 (17.6) | p = 0.031 |
ESRD | 11 (3.3) | 0 (0) | p = 0.609 |
CVA | 37 (10.9) | 1 (2.9) | p = 0.231 |
CAD | 29 (8.6) | 2 (5.9) | p = 0.999 |
Arrhythmia | 22 (6.5) | 3 (8.8) | p = 0.489 |
VHD | 5 (1.5) | 0 (0) | p = 0.999 |
ILD | 3 (0.9) | 0 (0) | p = 0.999 |
Asthma | 2 (0.6) | 0 (0) | p = 0.999 |
COPD | 4 (1.2) | 0 (0) | p = 0.999 |
Dementia | 11 (3.3) | 2 (5.9) | p = 0.337 |
Heart failure | 7 (2.1) | 1 (2.9) | p = 0.539 |
RA | 0 (0) | 2 (5.9) | p = 0.008 |
Gout | 8 (2.4) | 3 (8.8) | p = 0.069 |
Hyperthyroidism | 1 (0.3) | 1 (2.9) | p = 0.175 |
HBV infection | 7 (2.1) | 1 (2.9) | p = 0.539 |
HCV infection | 9 (2.7) | 1 (2.9) | p = 0.999 |
Hepatitis | 3 (0.9) | 1 (2.9) | p = 0.320 |
Liver cirrhosis | 5 (1.5) | 0 (0) | p = 0.999 |
Anemia | 6 (1.8) | 2 (5.9) | p = 0.160 |
Tuberculosis | 1 (0.3) | 1 (2.9) | p = 0.175 |
GI disease | 36 (10.7) | 0 (0) | p = 0.060 |
Arsenism | 6 (1.8) | 2 (5.9) | p = 0.160 |
Immunocompromised | 121 (35.8) | 17 (50) | p = 0.135 |
